Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ABBV-8E12 for early Alzheimer's disease has completed and results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ABBV-8E12 (ABBV-8E12)

Snippet

Sponsor: AbbVie | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-08-26